For example, the 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery recommend measuring hs-cTnT or hs-cTnI in individuals with known cardiovascular disease, cardiovascular risk factors (including age ≥ 65 years), or symptoms suggestive of cardiovascular disease. This evidence concerns the gene TNNI3 and cardiovascular disorder.